Intellectual PropertyPatent
Patent Cases to Watch in the Second Half of 2024: Implications for IP Strategy
This long-form analysis surveys the patent decisions and pending issues that reshaped patent law around 2024 and into 2025, and explains what each means for portfolio owners. It covers the Federal Circuit's en banc LKQ v. GM decision overhauling design-patent obviousness, the design-patent damages framework that makes those patents so valuable, the enablement fallout from Amgen v. Sanofi, the persistent uncertainty of Section 101 eligibility after Alice and Mayo, the Supreme Court's history-and-tradition turn in Vidal v. Elster, the USPTO's evolving examination guidance, developments at the PTAB including the long-running Fintiv discretionary-denial saga, and trends in patent damages and apportionment. For each area the article states the issue, its status and known aftermath, and the concrete IP-strategy implication for prosecution, portfolio management, and litigation. It is written as durable strategic guidance, candidly flagging where outcomes have continued to evolve since 2024. The goal is to help inventors, in-house counsel, and litigators position their portfolios against a moving body of law.